Portfolio company
Auransa
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops precision medicines for cancer and other diseases using an artificial intelligence platform to identify novel therapies and patient subgroups.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Auron Therapeutics
This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.
Serinus Biosciences
This company develops an artificial intelligence platform to design cancer therapeutics and combination therapies for the pharmaceutical and precision medicine industries.
Aureka Biotechnologies
The company develops artificial intelligence platforms and antibody therapeutics for pharmaceutical and biotechnology organisations to accelerate the discovery and design of medicines.
Meliora Therapeutics
This company develops a machine-learning platform to identify drug mechanisms and create precision oncology treatments for pharmaceutical partners and cancer patients.
Asylia Diagnostics
This company develops an artificial intelligence platform to identify biomarkers and drug targets for precision immunotherapy for pharmaceutical and diagnostic firms.
D3 Bio
This biotechnology company develops precision medicines and oncology therapeutics for patients with cancer and immunological conditions.
Allorion
This biotechnology company develops small-molecule drugs for patients with cancer and autoimmune diseases using its proprietary drug discovery platforms.
Celsius Therapeutics
The company develops precision medicines for patients with autoimmune diseases and cancer by using single-cell genomic sequencing and machine learning to identify drug targets.
